Ftse Mib
34.504,62
-0,45%
DAX
18.494,89
-0,33%
S&P 500
5.350,07
0,06%
NASDAQ
17.168,33
0,21%
Bitcoin
69.831,95
0,26%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sophiris Bio Inc (SPHS) Sophiris Bio Inc (SPHS) Notizie

SPHS

Sophiris Bio (SPHS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SPHS
DataOraFonteTitoloSimboloCompagnia
11/03/202021:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SPHSSophiris Bio Inc
14/02/202020:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SPHSSophiris Bio Inc
23/12/201922:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SPHSSophiris Bio Inc
13/11/201912:01Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:SPHSSophiris Bio Inc
08/11/201922:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SPHSSophiris Bio Inc
21/10/201914:00PR Newswire (US)Sophiris Bio Receives Positive Feedback from FDA Regarding Phase 3 Localized Prostate Cancer Clinical Trial DesignNASDAQ:SPHSSophiris Bio Inc
08/10/201922:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SPHSSophiris Bio Inc
06/09/201923:22Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SPHSSophiris Bio Inc
06/09/201921:03Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SPHSSophiris Bio Inc
30/08/201914:00PR Newswire (US)Sophiris Bio Announces Completion of $4.0 Million Registered Direct OfferingNASDAQ:SPHSSophiris Bio Inc
30/08/201914:00PR Newswire (US)Sophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceNASDAQ:SPHSSophiris Bio Inc
28/08/201912:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SPHSSophiris Bio Inc
27/08/201914:12PR Newswire (US)Sophiris Bio Announces $4.0 Million Registered Direct OfferingNASDAQ:SPHSSophiris Bio Inc
19/06/201914:30PR Newswire (US)Sophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical T...NASDAQ:SPHSSophiris Bio Inc
09/05/201922:05PR Newswire (US)Sophiris Bio Reports First Quarter 2019 Financial ResultsNASDAQ:SPHSSophiris Bio Inc
30/04/201922:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SPHSSophiris Bio Inc
30/04/201922:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SPHSSophiris Bio Inc
02/04/201922:05PR Newswire (US)Sophiris Bio to Present at Two Upcoming Investor ConferencesNASDAQ:SPHSSophiris Bio Inc
13/03/201922:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SPHSSophiris Bio Inc
13/03/201921:05PR Newswire (US)Sophiris Bio Reports Fourth Quarter 2018 and Year-end Financial Results and Recent Corporate HighlightsNASDAQ:SPHSSophiris Bio Inc
21/12/201822:51Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SPHSSophiris Bio Inc
17/12/201814:00PR Newswire (US)Sophiris Bio Provides Updates on Phase 2b Localized Prostate Cancer TrialNASDAQ:SPHSSophiris Bio Inc
15/11/201822:05PR Newswire (US)Sophiris Bio to Present at the Piper Jaffray Healthcare ConferenceNASDAQ:SPHSSophiris Bio Inc
13/11/201822:05PR Newswire (US)Sophiris Bio Reports Third Quarter 2018 Financial Results and Recent Corporate HighlightsNASDAQ:SPHSSophiris Bio Inc
25/09/201814:00PR Newswire (US)Sophiris Bio to Present at the Cantor Global Healthcare ConferenceNASDAQ:SPHSSophiris Bio Inc
20/09/201819:33Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SPHSSophiris Bio Inc
14/09/201814:00PR Newswire (US)Sophiris Bio Extends the Interest Only Period under its Loan and Security AgreementNASDAQ:SPHSSophiris Bio Inc
29/08/201822:30PR Newswire (US)Sophiris Bio to Present at the H.C. Wainwright 20th Annual Global Investment ConferenceNASDAQ:SPHSSophiris Bio Inc
29/08/201814:00PR Newswire (US)Sophiris Bio Updates on Phase 2b Localized Prostate Cancer TrialNASDAQ:SPHSSophiris Bio Inc
14/08/201822:05PR Newswire (US)Sophiris Bio Reports Second Quarter 2018 Financial Results and Recent Corporate HighlightsNASDAQ:SPHSSophiris Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SPHS

La tua Cronologia

NASDAQ
ARCL
EU
E764S
E764S
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network